Short-and long-term outcomes of acute upper extremity arterial thromboembolism

Annals of Thoracic and Cardiovascular Surgery

Volumn 16, Issue 1, 2010, Pages 31-34

  Magishi, Katsuaki ^a   Izumi, Yuichi ^a   Shimizu, Noriyuki ^a  

^a NAYORO CITY UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Thromboembolectomy; Thromboembolism; Upper extremity

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ACUTE DISEASE; AGED; ARM; ARTICLE; CATHETERIZATION; EMBOLECTOMY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; RECURRENT DISEASE; RETROSPECTIVE STUDY; THROMBECTOMY; THROMBOEMBOLISM; TIME; TREATMENT OUTCOME; VASCULARIZATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CATHETERIZATION, PERIPHERAL; EMBOLECTOMY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RETROSPECTIVE STUDIES; THROMBECTOMY; THROMBOEMBOLISM; TIME FACTORS; TREATMENT OUTCOME; UPPER EXTREMITY;

EID: 77649121219     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Haimovici H. Arterial embolism of the extremities and technique of embolectomy, In: Asher E ed.; Vascular Surgery 5th ed. Massachusetts: Backwell, 2003; pp 388-408.
2. Karapolat S, Dag Ö, Abanoz M, Aslan M. Arterial embolectomy: a retrospective evaluation of 730 cases over 20 years. Surg Today 2006; 36: 416-9.
3. Ueberrueck T, Marusch F, Schmidt H, Gastinger I. Risk factors and manegement of arterial emboli of the upper and lower extremities. J Cardiovasc Surg (Torino) 2007; 48: 181-6.
4. Licht PB, Balezantis T, Wolff B, Baudier JF, Røder OC. Long-term outcome following thromboembolectomy in the upper extremity. Eur J Vasc Endovasc Surg 2004; 28: 508-12.
5. Staudacher M, Böhm C, End A, Haberzettl C, Müller MR, et al. Embolic occlusion of arteries of the upper extremity. Vasa 1991; 20: 358-64.
6. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-57.
7. Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation. JAMA 2003; 290: 2685-92.
8. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370: 493-503.
9. Guidelines for manegement of anticoagulant and anti-platelet therapy in cardiovascular disease (JCS 2004). Circ J 2004; 68 (Suppl IV): 1153-219. (in Jpse.)
10. Yamaguchi T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Stroke 2000; 31: 817-21.
11. Koyama T, Funai S, Nishimura K, Kanno M, Abe H, et al. Acute arterial obstruction of the upper extrimities. Jpn J Vasc Surg 2000; 9: 479-83. (in Jpse. with Engl. abstr.)
12. Puma JA, Haq SA, Sacchi TJ. Acute upper extremity arterial occlusion: a novel role for the use of rheolytic thrombectomy and intravascular ultrasound. Catheter Cardiovasc Interv 2005; 66: 291-6.
13. Johnson SP, Durham JD, Subber SW, Gordon M, Rutherford R, et al. Acute arterial occlusions of the small vessels of the hand and forearm: treatment with regional urokinase therapy. J Vasc Interv Radiol 1999; 10: 869-76.
14. Becqemin JP, Kovarsky S. Atrial emboli of the lower limbs: analysis of risk factors for mortality and amputation. Association Universitaire de Recherche en Chirurgie. Ann Vasc Surg 1995; 9 (Suppl): S32-8.